Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Diapharm
Diapharm
Activities:
Regulatory
Pharmaceutical
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Regulatory
Diapharm authorised to assist medical device registration in Switzerland
Procedural changes were made in May 2021 in relation to the marketing and distribution of medical devices in Switzerland
Regulatory
Diapharm becomes European Authorised Representative
Companies based outside the EU that want to market their products in it must appoint a representative. Diapharm has been certified as such for medical devices
Pharmaceutical
Diapharm Analytics joins the Tentamus Group
The pharmaceutical laboratory Diapharm Analytics GmbH in Oldenburg, Germany, is joining the Tentamus Group
Research & Development
Diapharm opens new Netherlands branch
The company will bring quality assurance, pharmacovigilance and regulatory affairs services to the Benelux region
Regulatory
Bert Verhage appointed Manager of new Diapharm BV
Regulatory
Dr Ursel Nait joins regulatory specialist Diapharm
She has been named Senior Manager GMP Services at the German firm
Finance
SU BioMedicine and Diapharm collaborate to register and market high quality Chinese medicines in Europe
New venture will support the unmet medical/societal need for cure and care products for personalised health strategies
Subscribe now